Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVRNASDAQ:CLGNNYSE:INFUNASDAQ:KRMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$3.79-6.7%$4.35$2.34▼$8.79$146.41MN/A282,179 shs240,616 shsCLGNCollPlant Biotechnologies$1.36-1.4%$1.95$1.32▼$5.48$17.55M1.7734,449 shs63,455 shsINFUInfuSystem$6.24+2.0%$5.68$4.61▼$9.97$131.14M1.81114,750 shs325,371 shsKRMDKORU Medical Systems$3.58-1.4%$2.99$1.86▼$5.05$167.49M0.43142,450 shs358,582 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global0.00%-0.25%-6.88%+11.54%+405,999,900.00%CLGNCollPlant Biotechnologies0.00%-6.12%-55.91%-46.51%-72.23%INFUInfuSystem0.00%-2.08%+5.88%+13.75%-10.40%KRMDKORU Medical Systems0.00%+7.40%+31.05%+42.91%+36.98%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/ACLGNCollPlant Biotechnologies3.0718 of 5 stars3.75.00.00.02.70.00.6INFUInfuSystem2.4485 of 5 stars2.02.00.00.02.04.21.9KRMDKORU Medical Systems3.11 of 5 stars3.53.00.00.02.92.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50335.36% UpsideCLGNCollPlant Biotechnologies 3.33Buy$11.50745.59% UpsideINFUInfuSystem 4.00Strong Buy$13.00108.33% UpsideKRMDKORU Medical Systems 3.00Buy$4.5025.70% UpsideCurrent Analyst Ratings BreakdownLatest CLGN, AVR, INFU, and KRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.005/8/2025INFUInfuSystemB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.50(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.70M50.62N/AN/A$1.74 per share2.18CLGNCollPlant Biotechnologies$2.47M7.00N/AN/A$1.18 per share1.15INFUInfuSystem$137.58M0.95$0.49 per share12.79$2.47 per share2.53KRMDKORU Medical Systems$33.65M4.91N/AN/A$0.37 per share9.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies Global-$76.29MN/A0.00N/AN/AN/AN/AN/AN/ACLGNCollPlant Biotechnologies-$16.61M-$1.22N/AN/AN/A-560.92%-87.33%-65.31%7/16/2025 (Estimated)INFUInfuSystem$870K$0.14104.0220.13N/A1.12%2.78%1.41%N/AKRMDKORU Medical Systems-$6.07M-$0.11N/AN/AN/A-15.09%-30.43%-19.41%8/6/2025 (Estimated)Latest CLGN, AVR, INFU, and KRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/4/2025Q1 2025CLGNCollPlant Biotechnologies-$0.37-$0.13+$0.24-$0.13$9.76 million$2.06 million5/13/2025Q1 2025AVRAnteris Technologies GlobalN/A-$0.61N/A-$0.61N/AN/A5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ACLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/A3.673.65CLGNCollPlant BiotechnologiesN/A4.484.23INFUInfuSystem0.501.981.59KRMDKORU Medical Systems0.012.442.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ACLGNCollPlant Biotechnologies21.69%INFUInfuSystem71.13%KRMDKORU Medical Systems58.60%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies GlobalN/ACLGNCollPlant Biotechnologies9.60%INFUInfuSystem11.40%KRMDKORU Medical Systems20.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.06 millionN/AN/ACLGNCollPlant Biotechnologies7012.72 million11.50 millionOptionableINFUInfuSystem41021.02 million19.10 millionOptionableKRMDKORU Medical Systems8046.14 million36.64 millionOptionableCLGN, AVR, INFU, and KRMD HeadlinesRecent News About These CompaniesAlbion Financial Group UT Decreases Stock Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)June 30 at 6:33 AM | marketbeat.comKRMD KORU Medical Systems, Inc. - Seeking AlphaJune 28 at 12:51 PM | seekingalpha.comKORU Medical Systems to join Russell 3000 and 2000 indexesJune 11, 2025 | msn.comKORU Medical Systems to Join Russell 3000® and Russell 2000® IndexesJune 11, 2025 | businesswire.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Sees Significant Decrease in Short InterestJune 1, 2025 | marketbeat.comKORU Medical Systems holds annual shareholder meetingMay 17, 2025 | uk.investing.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comHere's What Analysts Are Forecasting For KORU Medical Systems, Inc. (NASDAQ:KRMD) After Its First-Quarter ResultsMay 10, 2025 | finance.yahoo.comKORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue EstimatesMay 7, 2025 | zacks.comKORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue GuidanceMay 7, 2025 | businesswire.comEven after rising 14% this past week, KORU Medical Systems (NASDAQ:KRMD) shareholders are still down 75% over the past five yearsMay 1, 2025 | uk.finance.yahoo.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 5.80%April 23, 2025 | aaii.comAWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 7.49%April 21, 2025 | aaii.comAWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Down 9.22%April 10, 2025 | aaii.comAKoru Medical management to meet with Craig-HallumApril 9, 2025 | markets.businessinsider.comKORU Medical Systems, Inc.'s (NASDAQ:KRMD) market cap dropped US$17m last week; individual investors who hold 43% were hit as were institutionsMarch 20, 2025 | finance.yahoo.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comKoru Medical reports Q4 EPS (13c), consensus (2c)March 12, 2025 | markets.businessinsider.comKoru Medical sees FY25 revenue $38M-$39M, consensus $38.4MMarch 12, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLGN, AVR, INFU, and KRMD Company DescriptionsAnteris Technologies Global NASDAQ:AVR$3.79 -0.27 (-6.65%) As of 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.CollPlant Biotechnologies NASDAQ:CLGN$1.36 -0.02 (-1.45%) As of 03:59 PM EasternCollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.InfuSystem NYSE:INFU$6.24 +0.12 (+1.96%) As of 04:00 PM EasternInfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.KORU Medical Systems NASDAQ:KRMD$3.58 -0.05 (-1.38%) As of 04:00 PM EasternKORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
